94 related articles for article (PubMed ID: 25581457)
1. Increased risk of salivary gland cancer among women with a previous cancer diagnosis.
Falchook AD; Zevallos JP; Chera BS
Head Neck; 2016 Apr; 38 Suppl 1():E446-51. PubMed ID: 25581457
[TBL] [Abstract][Full Text] [Related]
2. Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer.
Yesensky J; Kyrillos A; Kuchta K; Yao K; Wang CH; Bhayani MK
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):303-308. PubMed ID: 29039234
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of breast cancer development after diagnosis of salivary gland tumour.
In der Maur CD; Klokman WJ; van Leeuwen FE; Tan IB; Rutgers EJ; Balm AJ
Eur J Cancer; 2005 Jun; 41(9):1311-5. PubMed ID: 15939266
[TBL] [Abstract][Full Text] [Related]
4. Second primaries after major salivary gland cancer.
Megwalu UC; Shin EJ
Otolaryngol Head Neck Surg; 2011 Aug; 145(2):254-8. PubMed ID: 21493280
[TBL] [Abstract][Full Text] [Related]
5. The rising incidence of major salivary gland cancer in the United States.
Del Signore AG; Megwalu UC
Ear Nose Throat J; 2017 Mar; 96(3):E13-E16. PubMed ID: 28346649
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland cancer in the United States.
Sun EC; Curtis R; Melbye M; Goedert JJ
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1095-100. PubMed ID: 10613342
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands.
Valstar MH; Schaapveld M; van den Broek EC; van Velthuysen MF; de Ridder M; Schmidt MK; van Dijk BAC; Balm AJM; Smeele LE
Cancer Med; 2021 Jan; 10(1):424-434. PubMed ID: 33247629
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland second cancer after bone sarcoma treatment.
Longhi A; Errani C; Gambarotti M; Ferrari C; Kreshak J; Panagopoulos GN; Mavrogenis AF; Donati D
Eur J Orthop Surg Traumatol; 2015 Oct; 25(7):1201-4. PubMed ID: 26174415
[TBL] [Abstract][Full Text] [Related]
9. Second primary cancer after major salivary gland carcinoma.
Hirvonen K; Rantanen M; Haapaniemi A; Pitkäniemi J; Malila N; Mäkitie AA
Head Neck; 2018 Feb; 40(2):251-258. PubMed ID: 28960648
[TBL] [Abstract][Full Text] [Related]
10. An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010).
de Ridder M; Balm AJ; Smeele LE; Wouters MW; van Dijk BA
Cancer Epidemiol; 2015 Feb; 39(1):14-20. PubMed ID: 25454260
[TBL] [Abstract][Full Text] [Related]
11. Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis.
Yang J; Wei R; Song X; Sun X; Wang H; Liu Q; Hu L; Yu H; Wang D
Head Neck; 2021 Jun; 43(6):1769-1779. PubMed ID: 33590552
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland cancer and risk of subsequent skin cancer.
Spitz MR; Sider JG; Newell GR
Head Neck; 1990; 12(3):254-6. PubMed ID: 2358338
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Demographic and Socioeconomic Factors on Major Salivary Gland Cancer Survival.
Olarte LS; Megwalu UC
Otolaryngol Head Neck Surg; 2014 Jun; 150(6):991-8. PubMed ID: 24647644
[TBL] [Abstract][Full Text] [Related]
15. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and risk of second primary malignancies after radiotherapy in major salivary gland carcinomas: A retrospective study using SEER database.
Feng Y; Qian K; Guo K; Shi Y; Zhou J; Wang Z
Head Neck; 2024 May; 46(5):1201-1209. PubMed ID: 38284127
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence.
Valstar MH; de Ridder M; van den Broek EC; Stuiver MM; van Dijk BAC; van Velthuysen MLF; Balm AJM; Smeele LE
Oral Oncol; 2017 Mar; 66():93-99. PubMed ID: 28249655
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
Marti JL; Jain KS; Morris LG
Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
[TBL] [Abstract][Full Text] [Related]
19. Incidence of second primary breast cancer among patients with a first primary salivary gland tumor.
Abbey LM; Schwab BH; Landau GC; Perkins ER
Cancer; 1984 Oct; 54(7):1439-42. PubMed ID: 6467165
[TBL] [Abstract][Full Text] [Related]
20. Nomograms for predicting long-term overall survival and cancer-specific survival in patients with major salivary gland cancer: a population-based study.
Li Y; Ju J; Liu X; Gao T; Wang Z; Ni Q; Ma C; Zhao Z; Ren Y; Sun M
Oncotarget; 2017 Apr; 8(15):24469-24482. PubMed ID: 28160551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
